192 related articles for article (PubMed ID: 32734520)
21. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
[TBL] [Abstract][Full Text] [Related]
22. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Rakovitch E; Nofech-Mozes S; Hanna W; Baehner FL; Saskin R; Butler SM; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Robertson SJ; Slodkowska E; Fong C; Anderson JM; Jamshidian F; Miller DP; Cherbavaz DB; Shak S; Paszat L
Breast Cancer Res Treat; 2015 Jul; 152(2):389-98. PubMed ID: 26119102
[TBL] [Abstract][Full Text] [Related]
23. Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.
Hamilton SN; Nichol A; Wai E; Gondara L; Velásquez García HA; Speers C; Diocee R; Truong P
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):381-388. PubMed ID: 30253237
[TBL] [Abstract][Full Text] [Related]
24. Post-operative radiotherapy for ductal carcinoma in situ of the breast.
Goodwin A; Parker S; Ghersi D; Wilcken N
Cochrane Database Syst Rev; 2013 Nov; (11):CD000563. PubMed ID: 24259251
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
Bijker N; Peterse JL; Duchateau L; Julien JP; Fentiman IS; Duval C; Di Palma S; Simony-Lafontaine J; de Mascarel I; van de Vijver MJ
J Clin Oncol; 2001 Apr; 19(8):2263-71. PubMed ID: 11304780
[TBL] [Abstract][Full Text] [Related]
26. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.
Warren JL; Weaver DL; Bocklage T; Key CR; Platz CE; Cronin KA; Ballard-Barbash R; Willey SC; Harlan LC
Cancer; 2005 Nov; 104(9):1840-8. PubMed ID: 16136599
[TBL] [Abstract][Full Text] [Related]
27. Post-operative radiotherapy for ductal carcinoma in situ of the breast.
Goodwin A; Parker S; Ghersi D; Wilcken N
Cochrane Database Syst Rev; 2009 Oct; (4):CD000563. PubMed ID: 19821272
[TBL] [Abstract][Full Text] [Related]
28. A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.
Van Bockstal MR; Agahozo MC; Koppert LB; van Deurzen CHM
Int J Cancer; 2020 Mar; 146(5):1189-1197. PubMed ID: 31018242
[TBL] [Abstract][Full Text] [Related]
29. Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCIS.
Paszat L; Sutradhar R; Zhou L; Nofech-Mozes S; Rakovitch E
Clin Breast Cancer; 2019 Feb; 19(1):35-46. PubMed ID: 30190195
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community.
Hassett MJ; Jiang W; Habel LA; Nekhlyudov L; Achacoso N; Acton L; Schnitt SJ; Schrag D; Punglia RS
Breast Cancer Res Treat; 2016 Feb; 155(3):541-9. PubMed ID: 26843057
[TBL] [Abstract][Full Text] [Related]
31. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
[TBL] [Abstract][Full Text] [Related]
32. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
[TBL] [Abstract][Full Text] [Related]
33. Post-operative radiotherapy for ductal carcinoma in situ of the breast.
Goodwin A; Parker S; Ghersi D; Wilcken N
Cochrane Database Syst Rev; 2009 Jul; (3):CD000563. PubMed ID: 19588320
[TBL] [Abstract][Full Text] [Related]
34. Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results.
Sneige N; McNeese MD; Atkinson EN; Ames FC; Kemp B; Sahin A; Ayala AG
Hum Pathol; 1995 Jun; 26(6):642-9. PubMed ID: 7774895
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
36. Post-operative radiotherapy for ductal carcinoma in situ of the breast.
Goodwin A; Parker S; Ghersi D; Wilcken N
Cochrane Database Syst Rev; 2009 Jan; (1):CD000563. PubMed ID: 19160183
[TBL] [Abstract][Full Text] [Related]
37. Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer.
Groen EJ; van der Noordaa MEM; Schaapveld M; Sonke GS; Mann RM; van Ramshorst MS; Lips EH; Vrancken Peeters MTFD; van Duijnhoven FH; Wesseling J
Breast Cancer Res Treat; 2021 Aug; 189(1):213-224. PubMed ID: 33945043
[TBL] [Abstract][Full Text] [Related]
38. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
Frank S; Dupont A; Teixeira L; Porcher R; De Roquancourt A; Giacchetti S; Espié M; Cuvier C
Breast; 2016 Feb; 25():51-6. PubMed ID: 26573444
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast.
Lalani N; Paszat L; Sutradhar R; Thiruchelvam D; Nofech-Mozes S; Hanna W; Slodkowska E; Done SJ; Miller N; Youngson B; Tuck A; Sengupta S; Elavathil L; Chang MC; Jani PA; Bonin M; Rakovitch E
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1017-24. PubMed ID: 25220719
[TBL] [Abstract][Full Text] [Related]
40. Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
Van Bockstal M; Lambein K; Smeets A; Slembrouck L; Neven P; Nevelsteen I; Weltens C; Van Limbergen E; Christiaens MR; Van Ongeval C; Wildiers H; Libbrecht L; Floris G
Eur J Surg Oncol; 2019 Apr; 45(4):550-559. PubMed ID: 30454971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
